NASDAQ: CNTG - Centogene N.V.

Rentabilité sur six mois: -70.32%
Secteur: Healthcare

Calendrier des promotions Centogene N.V.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services.

plus de détails
In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

EBITDA -0.0045
EV/EBITDA -2.32
IPO date 2019-11-07
ISIN NL0014040206
Industry Health Care Providers & Services
P/BV 2.69
P/S 3.25
Sector Health Care
Валюта usd
Валюта отчета eur
Выручка 0.0405
Сайт https://www.centogene.com
Цена ао 0.2238
Число акций ао 0.02681 млрд
Changement de prix par jour: 0% (0.1211)
Changement de prix par semaine: -9.9% (0.1344)
Changement de prix par mois: +34.56% (0.09)
Changement de prix sur 3 mois: -39.45% (0.2)
Changement de prix sur six mois: -70.32% (0.408)
Changement de prix par an: -89.91% (1.2)
Evolution du prix sur 3 ans: -97.66% (5.17)
Evolution du prix sur 5 ans: -99.07% (13.05)
Evolution des prix sur 10 ans: 0% (0.1211)
Evolution des prix depuis le début de l'année: 0% (0.1211)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0.6114 10
P/BV -1.48 0
P/E 0 0
EV/EBITDA -2.93 0
Total: 5

Efficacité

Nom Signification Grade
ROA, % -45.07 0
ROE, % 137.55 10
Total: 3.33

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -2.2 10
Total: 9.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -2.54 0
Rentabilité Ebitda, % 142.23 10
Rentabilité EPS, % -94.96 0
Total: 5.6
Plus de détails

Établissements Volume Partager, %
Platinum Investment Management Ltd 2377150 8.61
Wells Fargo & Company 206389 0.75
Acadian Asset Management. LLC 24703 0.09
Blackrock Inc. 21578 0.08
Millennium Management LLC 19731 0.07
Morgan Stanley 18231 0.07
Stifel Financial Corporation 16450 0.06
Barclays PLC 15348 0.06
Geode Capital Management, LLC 11156 0.04
Meeder Asset Management, Inc. 138 0



Superviseur Titre d'emploi Paiement Année de naissance
Ms. Kim Stratton CEO & Member of Management Board 932.62k 1962 (63 année)
Mr. Jose Miguel Coego Rios CFO, Legal & IT and Member of Management Board 323.87k 1974 (51 année)
Dr. Peter Bauer M.D. Interim MD, Chief Medical & Genomic Officer and Member of Management Board 186.31k 1970 (55 années)
Dr. Andrin Oswald M.D., Ph.D. Advisor 943.45k 1972 (53 année)
Mr. Ian Rentsch Chief Commercial Officer & GM of Pharma N/A 1976 (49 années)

Adresse: Germany, Rostock, Am Strande 7 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.centogene.com